Search

Your search keyword '"Kennedy Cheryl"' showing total 312 results

Search Constraints

Start Over You searched for: Author "Kennedy Cheryl" Remove constraint Author: "Kennedy Cheryl"
312 results on '"Kennedy Cheryl"'

Search Results

1. Obstacles to diagnostic investigation of a child with comorbid psychiatric conditions

2. Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study

3. Dynamic disability measures decrease the clinico-radiological gap in people with severely affected multiple sclerosis

4. Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis

5. Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency

6. Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report

16. Changes of Cine Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis Treated with Percutaneous Transluminal Angioplasty: A Case-control Study

23. Addressing intimate partner violence in substance-abuse treatment

27. Community Violence, PTSD, Hopelessness, Substance Use, and Perpetuation of Violence in an Urban Environment

31. War in the COVID-19 era: Mental health concerns in Armenia and Nagorno-Karabakh.

34. Prevalence of Radiologically Isolated Syndrome and White Matter Signal Abnormalities in Healthy Relatives of Multiple Sclerosis Patients

35. A Course on Terror Medicine: Content and Evaluations

37. Sensitivity and specificity for screening of chronic cerebrospinal venous insufficiency using a multimodal non-invasive imaging approach in patients with multiple sclerosis

39. Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS

40. Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial

42. Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis

43. A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing–remitting multiple sclerosis

45. Relationship between Immunological Markers and Short-Term Brain Volume Changes in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Interferon Beta-1a (P3.146)

46. Associations Between Changes in Ferritin Levels and Susceptibility-Weighted Imaging Filtered Phase in Patients with Relapsing-Remitting Multiple Sclerosis over Six Months Therapy with Interferon Beta-1a (P6.115)

47. Correlations between Immunological Biomarkers and Conventional and Advanced MRI Measures Following Interferon Beta-1a Treatment for Relapsing-Remitting Multiple Sclerosis (P3.147)

49. The Effect Of Cardiovascular Risk Factors On Lesion Burden And Brain Atrophy In Multiple Sclerosis (S54.006)

50. Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study

Catalog

Books, media, physical & digital resources